Lineage Cell Therapeutics (LCTX) EBIT (2010 - 2026)
Lineage Cell Therapeutics' (LCTX) quarterly EBIT came in at -$7.6 million in Q1 2026, down 16.73% year-on-year from -$9.1 million in Q1 2025, and down 15.96% quarter-over-quarter from -$6.5 million in Q4 2025.
Lineage Cell Therapeutics (LCTX) EBIT (2010 - 2026) Analysis & Trends
Lineage Cell Therapeutics' EBIT history runs 17 years deep, the most recent figure standing at -$7.6 million for Q1 2026.
- On a quarterly basis, EBIT fell 16.73% year-over-year to -$7.6 million in Q1 2026; TTM through Mar 2026 was -$37.7 million, a 76.85% decrease from a year earlier, with the FY2025 full-year figure at -$36.6 million, down 70.5% from the prior year.
- EBIT retreated to -$7.6 million in Q1 2026 per LCTX's latest filing, from -$6.5 million in the prior quarter.
- Across five years, EBIT topped out at -$3.8 million in Q3 2025 and bottomed at -$19.8 million in Q2 2025.
- The 5-year median for EBIT is -$6.4 million (2022), against an average of -$6.6 million.
- Across the five-year window, EBIT jumped 76.49% in 2022 and sank 237.14% in 2025, its largest moves.
- Year by year, EBIT stood at -$6.6 million in 2022, then rose by 4.17% to -$6.4 million in 2023, then grew by 19.68% to -$5.1 million in 2024, then declined by 28.14% to -$6.5 million in 2025, then dropped by 15.96% to -$7.6 million in 2026.
- Per Business Quant, the three latest LCTX EBIT figures stand at -$7.6 million (Q1 2026), -$6.5 million (Q4 2025), and -$3.8 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Lineage Cell Therapeutics | 251.15 Mn | 188.44 Mn | 1.73 Mn | -7.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.59 Mn |
| Dec 31, 2025 | -6.55 Mn |
| Sep 30, 2025 | -3.79 Mn |
| Jun 30, 2025 | -19.78 Mn |
| Mar 31, 2025 | -6.51 Mn |
| Dec 31, 2024 | -5.11 Mn |
| Sep 30, 2024 | -3.84 Mn |
| Jun 30, 2024 | -5.87 Mn |
| Mar 31, 2024 | -6.66 Mn |
| Dec 31, 2023 | -6.36 Mn |
| Sep 30, 2023 | -6.71 Mn |
| Jun 30, 2023 | -5.02 Mn |
| Mar 31, 2023 | -6.64 Mn |
| Dec 31, 2022 | -6.64 Mn |
| Sep 30, 2022 | -5.25 Mn |
| Jun 30, 2022 | -4.23 Mn |
| Mar 31, 2022 | -6.40 Mn |
| Dec 31, 2021 | -28.24 Mn |
| Sep 30, 2021 | -6.84 Mn |
| Jun 30, 2021 | -7.08 Mn |